Ann: Indian Distribution Agreement, page-6

First 6 Last

Share
Profile

Follow
havana19

424 Posts.

30

18/01/18

09:26

Post #: 30390922
Share

Originally posted by TerribleTadpole ↑

I suspect that the person/people at the ASX who decide which announcements are price sensitive only do a pretty cursory read and probably don't have in-depth knowledge of the company. In this case you'd have to know that Neurotech doesn't yet have FDA approval for its product in order to understand that a new distribution agreement won't have any immediate impact on the company's revenues.

My view — somewhat longer in term — is that these agreements, including the one with eemagine, are tremendously important even though they aren't yet producing any significant sales. We learned in Italy that even though we have all the necessary local/regional approvals to sell the device the medical profession seem to care primarily about FDA approval.

So it seems that we'll have to wait some months before the sales will start.

But when they do start I suspect that volumes and growth will be enormous. We have lined up sales, distribution, and support agreements in markets variously large, sophisticated and/or wealthy. We have an experienced design/manufacturing partner sorted to. We're all poised waiting for the critical piece to be ready.

I think of it as being like planning a road trip. It's a bit late to go shopping for a camper van after you've packed your bags and are ready to leave.

Our van is already sitting in the driveway, tanks full, ready for us to jump in and turn the key.

Our managers are doing an impressive job of implementing concrete measures in prepartion for the future.

Expand

thats a bit more upbeat than usual!

NTI Price at posting: 21.0¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

Chaos reigns markets – so let's take stock of where we're at ahead of December

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

There are more pages in this discussion • 4 more messages in this thread...

First 6 Last

Add NTI (ASX) to my watchlist

(20min delay)
Last 7.0¢		Change 0.001(1.45%)		Mkt cap ! $64.55M

Open	High	Low	Value	Volume
7.1¢	7.1¢	7.0¢	$16.67K	237.0K

Buyers (Bids)

No.	Vol.	Price($)
3	75250	6.9¢

Sellers (Offers)

Price($)	Vol.	No.
7.0¢	23082	1

View Market Depth

No.	Vol.	Price($)
4	589299	0.070
1	36231	0.069
5	240000	0.068
2	255000	0.067
3	262000	0.066

Price($)	Vol.	No.
0.072	100000	1
0.074	40000	1
0.075	738582	2
0.076	90000	1
0.077	190000	3

Last trade - 14.13pm 28/11/2024 (20 minute delay)

NTI (ASX) Chart

Ann: Indian Distribution Agreement, page-6

Top Stories

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

Chaos reigns markets – so let's take stock of where we're at ahead of December

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Buyers (Bids)

Sellers (Offers)